Arthur He HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
17
Avg Return
Past Year
Past Year
52%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
76.2%
Neutral
23.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $110 |
161%
upside
| 4 | +19% |
0
%
| 2 Mar ‘26 8 days ago |
|
|
|
Buy
Maintained
| $165 |
131%
upside
| 4 | +125% |
0
%
| 10 Feb ‘26 28 days ago |
|
|
|
Buy
Initiated
| $25 |
68%
upside
| 1 | +12% |
0
%
| 7 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $7 |
106%
upside
| 2 | +46% |
0
%
| 15 Aug ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $1.24 | – | 2 | +37% |
–
| 5 Aug ‘25 7 months ago |
|
|
|
Buy
Assumed
| $17 |
15%
upside
| 1 | +66% |
0
%
| 30 Jul ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | -49% |
0
%
| 29 Jul ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $20 |
146%
upside
| 2 | +27% |
0
%
| 17 Jun ‘25 8 months ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | -24% |
0
%
| 20 May ‘25 9 months ago |
|
|
|
Neutral
Reiterated
| – | – | 1 | – |
–
| 31 Mar ‘25 11 months ago |
|